Regulus Therapeutics
RGLS
#9133
Rank
$90.39 M
Marketcap
$1.38
Share price
-6.76%
Change (1 day)
-41.53%
Change (1 year)

Regulus Therapeutics (RGLS) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : $6.95 Million USD

According to Regulus Therapeutics's latest financial reports the company's total liabilities are $6.95 Million USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Regulus Therapeutics - Total liabilities on balance sheet (from 2011 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31$9.56 M-28.77%
2022-12-31$13.42 M-0.53%
2021-12-31$13.49 M16.57%
2020-12-31$11.57 M-47.53%
2019-12-31$22.06 M-34.68%
2018-12-31$33.78 M-20.69%
2017-12-31$42.59 M-4.47%
2016-12-31$44.58 M162.19%
2015-12-31$17 M-56.91%
2014-12-31$39.46 M33.3%
2013-12-31$29.6 M-28.53%
2012-12-31$41.42 M-50.9%
2011-12-31$84.37 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
$58.19 B 836,332.88%๐Ÿ‡ฌ๐Ÿ‡ง UK
$57.17 B 821,578.64%๐Ÿ‡ซ๐Ÿ‡ท France
$11.33 B 162,781.58%๐Ÿ‡บ๐Ÿ‡ธ USA
$63.16 B 907,689.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
$4.17 B 59,872.55%๐Ÿ‡บ๐Ÿ‡ธ USA
$72.12 M 936.63%๐Ÿ‡บ๐Ÿ‡ธ USA
$76.21 B 1,095,257.86%๐Ÿ‡บ๐Ÿ‡ธ USA